{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T01:23:40Z","timestamp":1792027420182,"version":"4.4.0"},"reference-count":33,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,5]]},"abstract":"<jats:sec>\n            <jats:title>Objective:<\/jats:title>\n            <jats:p>This study investigates Enhanced Recovery After Surgery (ERAS) protocols\u2019 impact on long-term opioid and sedative use following mastectomy with or without implant-based breast reconstruction (IBBR).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>ERAS protocols for patients undergoing mastectomy with or without IBBR are associated with decreased length of stay, increased rate of same-day discharge, decreased postoperative pain, and decreased postoperative opioid requirements. However, less is known about their effect on opioid and sedative use beyond 90 days after surgery.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>A retrospective review of all patients undergoing mastectomy with or without IBBR at a single institution between January 2013 and December 2019. Mastectomy ERAS protocols were implemented in February 2017, creating 2 groups: pre-ERAS and ERAS. Baseline characteristics and prevalence of chronic opioid and sedative use were compared. Univariable and multivariable logistic regression predicted factors associated with increased odds of chronic opioid and sedative use.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>A total of 756 patients were evaluated: 405 pre-ERAS and 351 ERAS. Post-ERAS, chronic opioid use decreased in opioid-naive (40% vs 30%, <jats:italic toggle=\"yes\">P<\/jats:italic>=0.024) and opioid-tolerant patients (58% vs 37%, <jats:italic toggle=\"yes\">P<\/jats:italic>=0.002), with no increase in chronic sedative use. There were decreased odds of chronic opioid use for all ERAS patients (OR=0.57, 95% CI: 0.42\u20130.76), and of IBBR patients, those receiving subcutaneous implants (OR=0.31, 95% CI: 0.20\u20130.48). There was increased chronic opioid-use odds if undergoing bilateral surgery (OR=1.54, 95% CI: 1.14\u20132.08), 2-stage reconstruction (OR=9.78, 95% CI: 5.94-16.09), and for patients with higher PACU pain scores (OR=1.09, 95% CI: 1.03\u20131.14) or &gt;150 discharge OMEs (OR=2.63, 95% CI: 1.48\u20134.68).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>ERAS protocols for mastectomy patients with or without IBR are associated with decreases in chronic opioid use, without concomitant increases in chronic sedative use.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/sla.0000000000006344","type":"journal-article","created":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T09:00:17Z","timestamp":1715936417000},"page":"787-795","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":5,"title":["Reducing Chronic Opioid Use"],"prefix":"10.1097","volume":"281","author":[{"given":"Kristen","family":"Jogerst","sequence":"first","affiliation":[{"name":"Department of General Surgery, Division of Surgical Oncology, Mayo Clinic Arizona, Phoenix, AZ"},{"name":"Department of Surgery, Massachusetts General Hospital, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikita","family":"Gupta","sequence":"additional","affiliation":[{"name":"Mayo Clinic School of Medicine, Phoenix, AZ"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heidi E.","family":"Kosiorek","sequence":"additional","affiliation":[{"name":"Department of Research-Biostatistics, Mayo Clinic Arizona, Phoenix, AZ"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeonsoo S.","family":"Lee","sequence":"additional","affiliation":[{"name":"Mayo Clinic School of Medicine, Phoenix, AZ"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sami","family":"Abujbarah","sequence":"additional","affiliation":[{"name":"Mayo Clinic School of Medicine, Phoenix, AZ"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Cronin","sequence":"additional","affiliation":[{"name":"Department of General Surgery, Division of Surgical Oncology, Mayo Clinic Arizona, Phoenix, AZ"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Casey","sequence":"additional","affiliation":[{"name":"Department of Surgery, Division of Plastic Surgery, Mayo Clinic Arizona, Phoenix, AZ"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Pockaj","sequence":"additional","affiliation":[{"name":"Department of General Surgery, Division of Surgical Oncology, Mayo Clinic Arizona, Phoenix, AZ"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,5,17]]},"reference":[{"key":"R2-20250617","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/dar.12541","article-title":"Addressing the prescription opioid crisis: Potential for hospital-based interventions?","volume":"36","author":"Kim","year":"2017","journal-title":"Drug Alcohol Rev"},{"key":"R3-20250617","doi-asserted-by":"crossref","first-page":"697","DOI":"10.15585\/mmwr.mm6626a4","article-title":"Vital signs: changes in opioid prescribing in the United States, 2006-2015","volume":"66","author":"Guy","year":"2017","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R4-20250617","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1186\/s12913-020-05390-4","article-title":"Clinical perspectives on hospitals\u2019 role in the opioid epidemic","volume":"20","author":"Mazurenko","year":"2020","journal-title":"BMC Health Serv Res"},{"key":"R6-20250617","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1001\/jama.2016.0130","article-title":"Opioids prescribed after low-risk surgical procedures in the United States, 2004-2012","volume":"315","author":"Wunsch","year":"2016","journal-title":"JAMA"},{"key":"R7-20250617","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7326\/M15-0038","article-title":"Opioid prescribing after nonfatal overdose and association with repeated overdose: a cohort study","volume":"164","author":"Larochelle","year":"2016","journal-title":"Ann Intern Med"},{"key":"R8-20250617","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/jhm.2102","article-title":"Opioid utilization and opioid-related adverse events in nonsurgical patients in US hospitals","volume":"9","author":"Herzig","year":"2014","journal-title":"J Hosp Med"},{"key":"R9-20250617","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1213\/ANE.0000000000002458","article-title":"Chronic opioid use after surgery: implications for perioperative management in the face of the opioid epidemic","volume":"125","author":"Hah","year":"2017","journal-title":"Anesth Analg"},{"key":"R10-20250617","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1097\/SLA.0000000000003549","article-title":"Postsurgical opioid prescriptions and risk of long-term use: an observational cohort study across the United States","volume":"273","author":"Young","year":"2021","journal-title":"Ann Surg"},{"key":"R11-20250617","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1200\/JCO.2016.70.3413","article-title":"Clinical prediction model and tool for assessing risk of persistent pain after breast cancer surgery","volume":"35","author":"Meretoja","year":"2017","journal-title":"J Clin Oncol"},{"key":"R12-20250617","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1054\/brst.2001.0386","article-title":"Immediate reconstruction in breast cancer surgery requires intensive post-operative pain treatment but the effects of axillary dissection may be more predictive of chronic pain","volume":"11","author":"Legeby","year":"2002","journal-title":"Breast"},{"key":"R13-20250617","first-page":"e59","article-title":"Postoperative pain management in DIEP flap breast reconstruction: identification of patients with poor pain control","volume":"10","author":"Bar-Meir","year":"2010","journal-title":"Eplasty"},{"key":"R14-20250617","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1001\/jamainternmed.2016.3298","article-title":"Incidence of and risk factors for chronic opioid use among opioid-naive patients in the postoperative period","volume":"176","author":"Sun","year":"2016","journal-title":"JAMA Intern Med"},{"key":"R15-20250617","doi-asserted-by":"crossref","first-page":"e1574","DOI":"10.1634\/theoncologist.2019-0868","article-title":"Prolonged opioid use after surgery for early-stage breast cancer","volume":"25","author":"Shen","year":"2020","journal-title":"Oncologist"},{"key":"R16-20250617","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1097\/PRS.0000000000003832","article-title":"Prescription opioid use among opioid-naive women undergoing immediate breast reconstruction","volume":"140","author":"Marcusa","year":"2017","journal-title":"Plast Reconstr Surg"},{"key":"R17-20250617","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1245\/s10434-019-08171-4","article-title":"Identifying factors predicting prolonged opioid use after mastectomy","volume":"27","author":"Woeste","year":"2020","journal-title":"Ann Surg Oncol"},{"key":"R18-20250617","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s10549-018-4991-8","article-title":"Enhanced recovery after surgery (ERAS\u00ae) pathways in breast reconstruction: systematic review and meta-analysis of the literature","volume":"173","author":"Offodile","year":"2019","journal-title":"Breast Cancer Res Treat"},{"key":"R19-20250617","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1097\/AJP.0000000000000792","article-title":"Enhanced Recovery After Surgery (ERAS\u00ae): a perspective review of postoperative pain management under ERAS\u00ae pathways and its role on opioid crisis in the United States","volume":"36","author":"Echeverria-Villalobos","year":"2020","journal-title":"Clin J Pain"},{"key":"R20-20250617","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.amjsurg.2019.07.017","article-title":"Mastectomy is no longer an indication for postoperative opioid prescription at discharge","volume":"218","author":"Rojas","year":"2019","journal-title":"Am J Surg"},{"key":"R21-20250617","doi-asserted-by":"crossref","first-page":"3436","DOI":"10.1245\/s10434-020-08386-w","article-title":"Same-day discharge after mastectomy: breast cancer surgery in the era of ERAS\u00ae","volume":"27","author":"Jogerst","year":"2020","journal-title":"Ann Surg Oncol"},{"key":"R22-20250617","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1097\/SLA.0000000000002969","article-title":"Patterns of initial opioid prescribing to opioid-naive patients","volume":"271","author":"Larach","year":"2020","journal-title":"Ann Surg"},{"key":"R23-20250617","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s12630-015-0520-y","article-title":"The prescription opioid epidemic: an overview for anesthesiologists","volume":"63","author":"Alam","year":"2016","journal-title":"Can J Anaesth"},{"key":"R25-20250617","doi-asserted-by":"crossref","first-page":"e170504","DOI":"10.1001\/jamasurg.2017.0504","article-title":"New persistent opioid use after minor and major surgical procedures in US adults","volume":"152","author":"Brummett","year":"2017","journal-title":"JAMA Surg"},{"key":"R26-20250617","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"A metadata-driven methodology and workflow process for providing translational research informatics support","volume":"42","author":"Harris","year":"2009","journal-title":"J Biomed Inform"},{"key":"R27-20250617","doi-asserted-by":"crossref","first-page":"103208","DOI":"10.1016\/j.jbi.2019.103208","article-title":"The REDCap consortium: building an international community of software platform partners","volume":"95","author":"Harris","year":"2019","journal-title":"J Biomed Inform"},{"key":"R28-20250617","first-page":"81","article-title":"PPM launches online opioid calculator","volume":"13","author":"Brennan","year":"2012","journal-title":"Pract Pain Manage"},{"key":"R29-20250617","doi-asserted-by":"crossref","first-page":"3318","DOI":"10.1200\/JCO.22.01966","article-title":"Effect of peritumoral infiltration of local anesthetic before surgery on survival in early breast cancer","volume":"41","author":"Badwe","year":"2023","journal-title":"J Clin Oncol"},{"key":"R30-20250617","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1097\/PRS.0000000000005435","article-title":"A cost-minimization analysis evaluating the use of liposomal bupivacaine in reconstructive plastic surgery procedures","volume":"143","author":"Little","year":"2019","journal-title":"Plast Reconstr Surg"},{"key":"R31-20250617","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1007\/s11912-021-01133-8","article-title":"Perioperative NSAIDs and long-term outcomes after cancer surgery: a systematic review and meta-analysis","volume":"23","author":"Shaji","year":"2021","journal-title":"Curr Oncol Rep"},{"key":"R32-20250617","doi-asserted-by":"crossref","first-page":"6395","DOI":"10.1245\/s10434-022-12141-8","article-title":"Postoperative hematomas in the era of outpatient mastectomy: is ketorolac really to blame?","volume":"29","author":"Abujbarah","year":"2022","journal-title":"Ann Surg Oncol"},{"key":"R33-20250617","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.bjps.2015.12.009","article-title":"Comparison of immediate postoperative pain in implant-based breast reconstructions","volume":"69","author":"Gassman","year":"2016","journal-title":"J Plast Reconstr Aesthet Surg"},{"key":"R34-20250617","doi-asserted-by":"crossref","first-page":"809","DOI":"10.5664\/jcsm.9724","article-title":"Past-year use or misuse of an opiod is associated with use of a sedative-hypnotic medication: a US National Survey on Drug Use and Health (NSDUH) study","volume":"18","author":"Tubbs","year":"2022","journal-title":"J Clin Sleep Med"},{"key":"R35-20250617","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1097\/PRS.0000000000004636","article-title":"Opioid use following outpatient breast surgery: are physicians part of the problem?","volume":"142","author":"Hart","year":"2018","journal-title":"Plast Reconstr Surg"},{"key":"R36-20250617","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s44186-022-00048-7","article-title":"How to teach ERAS\u00ae protocols: surgical residents\u2019 perspectives and perioperative practices for breast surgery patients","volume":"2","author":"Jogerst","year":"2023","journal-title":"Global Surg Educ"}],"container-title":["Annals of Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/SLA.0000000000006344","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T21:05:56Z","timestamp":1750194356000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/SLA.0000000000006344"}},"subtitle":["Long-term Impacts of Enhanced Recovery After Mastectomy Protocols"],"short-title":[],"issued":{"date-parts":[[2024,5,17]]},"references-count":33,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/sla.0000000000006344","relation":{},"ISSN":["0003-4932","1528-1140"],"issn-type":[{"value":"0003-4932","type":"print"},{"value":"1528-1140","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,17]]}}}